Table 1.
Socio-demographic and baseline characteristics according to stroke mechanism in French Guiana. India study-French Guiana
| Characteristics | All patients N = 298 |
Ischemic stroke N = 234 [78.5%] |
Intracerebral hemorrhage N = 64 [21.4%] |
|---|---|---|---|
| Demographic characteristics | |||
| Age | |||
| < 50 | 60 (20.1) | 43 (18.3) | 17 (26.5) |
| 50–65 | 106 (35.5) | 86 (36.7) | 20 (31.2) |
| 65–80 | 96 (32.2) | 77 (32.9) | 19 (29.6) |
| ≥80 | 36 (12) | 28 (11.9) | 8 (12.5) |
| Male gender | 190 (63.7) | 146 (62.3) | 44 (68.7) |
| Preexisting conditions | |||
| BMI± | |||
| < 20 | 16 (5.3) | 11 (4.7) | 5 (7.8) |
| 20–25 | 82 (27.5) | 60 (25.6) | 22 (34.3) |
| 25–30 | 82 (27.5) | 68 (29) | 14 (21.8) |
| > = 30 | 52 (17.4) | 41 (17.5) | 11 (17.1) |
| Unknown | 66 (22.1) | 54 (23) | 12 (18.7) |
| Hypertension± | 208 (70.2) | 164 (70.3) | 44 (69.8) |
| Diabetes± | 74 (24.9) | 67 (28.7) | 7 (10.9) |
| Hypercholesterolemia± | 50 (17) | 42 (18.1) | 8 (12.7) |
| Chronic heart failure± | 16 (5.4) | 12 (5.1) | 4 (6.2) |
| Alcohol ≥ 2 drinks/day± | 52 (17.9) | 35 (15.2) | 17 (27.8) |
| Tobacco status± | |||
| Current smoker | 64 (21.6) | 53 (22.7) | 11 (17.7) |
| Previous smoker | 48 (16.2) | 37 (15.8) | 11 (17.7) |
| Non smoker | 183 (62) | 143 (61.3) | 40 (64.5) |
| Atrial fibrillation± | 19 (6.5) | 17 (7.4) | 2 (3.1) |
| Prior medical history | |||
| Prior transient ischemic attack | 33 (11) | 33 (14.1) | 0 |
| Prior myocardial infarction | 8 (2.6) | 5 (2.1) | 3 (4.6) |
| Prior angina pectoris | 9 (3) | 6 (2.5) | 3 (4.6) |
| Prior history of lower limb arteriopathy | 13 (4.3) | 13 (5.5) | 0 |
| Prior history of vascular surgery | 7 (2.3) | 7 (2.9) | 0 |
| Prior history of angioplasty | 7 (2.3) | 6 (2.5) | 1 (1.5) |
| Pre-morbid treatment | |||
| Antiplatelet therapy | 41 (13.7) | 34 (14.5) | 7 (10.9) |
| Anticoagulant therapy± | 19 (6.4) | 10 (4.3) | 9 (14) |
| Antihypertensive drug± | 153 (51.6) | 120 (51.7) | 33 (51.5) |
| Statin± | 38 (12.7) | 31 (13.3) | 7 (10.9) |
| Oral antidiabetic drug± | 48 (16.2) | 44 (18.9) | 4 (6.2) |
| Psychotropic drug± | 15 (5) | 9 (3.8) | 6 (9.3) |
| Insulin± | 24 (8) | 21 (9) | 3 (4.6) |
| Oral contraception ±(woman only) | 7 (6.4) | 7 (7.9) | 0 |
| Substitution hormonotherapy ±(woman only) | 2 (1.9) | 0 | 2 (1.9) |
| Ischaemic stroke classification (n = 234) | |||
| Lacunar | 57 (24.3) | ||
| Large-artery | 38 (16.2) | ||
| Cardioembolism | 28 (11.9) | ||
| Other | 111 (47.4) | ||
| Admission NIHSS score± | |||
| 0–3 | 89 (31.4) | 75 (33.7) | 14 (22.9) |
| 4–9 | 97 (34.2) | 84 (37.8) | 13 (21.3) |
| ≥10 | 97 (34.2) | 63 (28.3) | 34 (55.7) |
| mRS at discharge± | |||
| 0 | 40 (14.3) | 37 (17.1) | 3 (4.8) |
| 1–2 | 102 (36.6) | 88 (40.7) | 14 (22.5) |
| 3–4 | 96 (34.5) | 67 (31) | 29 (46.7) |
± missing values: BMI = 66; HTA = 2; Diabetes = 1; Hypercholesterolemia = 4; Chronic heart failure = 3; Alcohol = 8;Tobbaco = 3; AF = 6; anticoagulant = 2; antihypertensive = 2; statin = 1; oral antidiabetic = 2; psychotropic = 1; insulin = 1; oral contraception = 2; Sub hormonotherapy = 4; pre stroke mRS = 1; NIHSS at admission = 15; Barthel score = 2